Lv11
10 积分 2022-03-16 加入
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
2小时前
已完结
MetastaticHER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
10天前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
4个月前
已完结
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
1年前
已完结
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
1年前
已完结
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
1年前
已完结
Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
1年前
已完结
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
1年前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
1年前
已完结
Efficacy of anti-HER2 drugs in the treatment of patients with HER2-mutated cancers: a systematic review and meta-analysis
1年前
已完结
皖公网安备34019202002308
